Nexcelom Blog Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug properties

Sangivamycin is an unsuccessful anti-cancer drug candidate that has proven to be a potent inhibitor of multiple viruses. The authors of this study hypothesized that this compound would also be active against SARS-CoV-2. The post Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug properties appeared first on Nexcelom Bioscience.